UP!
| Industry | Biopharmaceutical |
|---|---|
| Founded | 2010 |
| Headquarters | Redwood City, California, United States |
|
Key people
|
Dennis M. Lanfear (President, CEO & Chairman) |
| Website | www |
Coherus BioSciences is an American biopharmaceutical company focused on developing and commercializing biosimilar drugs.
Coherus BioSciences was founded in 2010 as a pure-play biosimilar company with headquarters in Redwood City, California. The company is publicly traded on the NASDAQ Stock Market with the tag NASDAQ:CHRS.
Coherus develops a type of biologic products called biosimilars.
2016 - Deloitte’s Technology Fast 500 award
| Period | Date | Adjusted Actuals EPS | GAAP EPS |
|---|---|---|---|
| Q3 2022 | 2022-11-07 | Future report Set alerts | |
| Q2 2022 | 2022-08-04 | -0.47 | -0.47 |
| Q1 2022 | 2022-05-05 | -1.24 | -1.24 |
| Q4 2021 | 2022-02-17 | -0.46 | -0.46 |
| Q3 2021 | 2021-11-08 | -0.34 | -0.34 |
| Q2 2021 | 2021-08-05 | -0.40 | -0.40 |
| Q1 2021 | 2021-05-06 | -2.22 | -2.22 |
| Q4 2020 | 2021-02-24 | 0.12 | 0.12 |
| Q3 2020 | 2020-11-05 | 0.00 | 0.00 |
| Q2 2020 | 2020-08-06 | 0.70 | 0.70 |
| 2016-03-01 | Lower Price Target | JPMorgan Chase & Co. | Overweight | $37.00 to $35.00 |
| 2016-01-19 | Initiated Coverage | Credit Suisse | Outperform | $25.00 |
| 2016-01-19 | Initiated Coverage | Credit Suisse Group AG | Outperform | $25.00 |
| 2015-11-23 | Initiated Coverage | Barclays | Overweight | $46.00 |
| 2015-11-23 | Initiated Coverage | Barclays PLC | Overweight | $46.00 |
| 2015-02-17 | Boost Price Target | JPMorgan Chase & Co. | Overweight | $20.00 to $35.00 |
| 2014-12-02 | Initiated Coverage | Credit Suisse | Outperform | $22.00 |
| 2014-12-02 | Initiated Coverage | JPMorgan Chase & Co. | Overweight | |
| 2014-12-01 | Initiated Coverage | Cowen and Company | Outperform | $45.00 |
| 2016-03-01 | Lower Price Target | JPMorgan Chase & Co. | Overweight | $37.00 to $35.00 |
| 2016-01-19 | Initiated Coverage | Credit Suisse | Outperform | $25.00 |
| 2016-01-19 | Initiated Coverage | Credit Suisse Group AG | Outperform | $25.00 |
| 2015-11-23 | Initiated Coverage | Barclays | Overweight | $46.00 |
| 2015-11-23 | Initiated Coverage | Barclays PLC | Overweight | $46.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In CHRS 154 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| BlackRock Inc. | 12.98M |
| TEMASEK HOLDINGS (PRIVATE) LTD | 7.38M |
| JPMORGAN CHASE & CO | 6.13M |
| ALLIANCEBERNSTEIN L.P. | 6.11M |
| Vanguard Group, Inc | 5.23M |
| STATE STREET CORP | 5.11M |
| Kohlberg Kravis Roberts & Co. L.P. | 3.04M |
| Aristotle Capital Boston, LLC | 2.14M |
| TIAA CREF INVESTMENT MANAGEMENT LLC | 2.08M |
| AMERIPRISE FINANCIAL INC | 1.83M |
| PERCEPTIVE ADVISORS LLC | 1.67M |
| BlackRock Fund Advisors | 1.56M |
| GEODE CAPITAL MANAGEMENT, LLC | 1.23M |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1.13M |
| PEREGRINE CAPITAL MANAGEMENT INC /MN/ | 1.12M |
UM